NCT00479505 - Study The Effects Of Different Doses Of UK-369,003 In Men With Overactive Bladder | Biotech Hunter

Enrollment

275

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions

Urinary Bladder, Overactive

Interventions

DRUG

UK-369,003

UK-369,003 100mg, 50mg, 25mg and 10mg doses in addition to placebo.

DRUG

Placebo

Trial Locations (52)

0

Pfizer Investigational Site, Medellín

2228

Pfizer Investigational Site, Miranda

4021

Pfizer Investigational Site, Kippa-Ring

5001

Pfizer Investigational Site, Aarau

8091

Pfizer Investigational Site, Zurich

15562

Pfizer Investigational Site, Cholargós

20100

Pfizer Investigational Site, Turku

26500

Pfizer Investigational Site, Rio

33100

Pfizer Investigational Site, Tampere

34090

Pfizer Investigational Site, Montpellier

35033

Pfizer Investigational Site, Rennes

35039

Pfizer Investigational Site, Marburg

45200

Pfizer Investigational Site, Kouvola

45468

Pfizer Investigational Site, Muelheim A.d. Ruhr

45500

Pfizer Investigational Site, Epirus

50139

Pfizer Investigational Site, Florence

65929

Pfizer Investigational Site, Frankfurt

69437

Pfizer Investigational Site, Lyon

75020

Pfizer Investigational Site, Paris

81925

Pfizer Investigational Site, München

83022

Pfizer Investigational Site, Rosenheim

90015

Pfizer Investigational Site, Cefalù

90100

Pfizer Investigational Site, Oulu

92380

Pfizer Investigational Site, Garches

2820945

Pfizer Investigational Site, Rancagua

8380419

Pfizer Investigational Site, Santiago

8380456

Pfizer Investigational Site, Santiago

V8T 5G1

Pfizer Investigational Site, Victoria

L4M 7G1

Pfizer Investigational Site, Barrie

N2N 2B9

Pfizer Investigational Site, Kitchener

M6A 3B5

Pfizer Investigational Site, Toronto

Unknown

Pfizer Investigational Site, Bogota

00100

Pfizer Investigational Site, Helsinki

04100

Pfizer Investigational Site, Latina

LV 1010

Pfizer Investigational Site, Riga

N-2390

Pfizer Investigational Site, Moelv

NO-0257

Pfizer Investigational Site, Oslo

41-400

Pfizer Investigational Site, Mysłowice

61-485

Pfizer Investigational Site, Poznan

70-111

Pfizer Investigational Site, Szczecin

70-451

Pfizer Investigational Site, Szczecin

70-467

Pfizer Investigational Site, Szczecin

53-020

Pfizer Investigational Site, Wroclaw

833 31

Pfizer Investigational Site, Bratislava

036 59

Pfizer Investigational Site, Martin

911 01

Pfizer Investigational Site, Trenčín

040 11

Pfizer Investigational Site, Košice

08208

Pfizer Investigational Site, Sabadell

07500

Pfizer Investigational Site, Manacor

NE7 7DN

Pfizer Investigational Site, High Heaton

TA1 5DA

Pfizer Investigational Site, Taunton

LS9 7TF

Pfizer Investigational Site, Leeds